CHRONIC WEIGHT MANAGEMENT
Clinical trials for CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill tame the obesity epidemic?
Disease control Recruiting nowThis Phase 3 trial is testing an experimental once-daily oral medication called ASC30 in adults with obesity or overweight who also have weight-related health conditions like high blood pressure or sleep apnea. The study aims to see if ASC30 can lead to significant weight loss ov…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE3 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a daily pill tame obesity and type 2 diabetes?
Disease control Recruiting nowThis trial is testing an experimental once-daily pill called ASC30 in adults who are overweight or have obesity and also have type 2 diabetes. The study aims to see if ASC30 can help with long-term weight loss and improve blood sugar control compared to a placebo. Participants wi…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE3 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New daily pill could help manage weight for years
Disease control Recruiting nowThis phase 3 trial tests a once-daily oral drug called aleniglipron for chronic weight management in 3600 adults with obesity or overweight who also have a weight-related health condition. Participants take the drug or a placebo for 76 weeks, along with diet and exercise changes.…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE3 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Daily pill aims to tackle weight and diabetes together
Disease control Recruiting nowThis phase 3 study tests aleniglipron, an oral medication taken once daily, for helping adults with obesity or overweight and type 2 diabetes manage their weight over the long term. Participants receive either aleniglipron or a placebo for 76 weeks. The main goal is to see how mu…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE3 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC